Table: Oncolys Biopharma -2017 parent results

Oncolys Biopharma

09/02/2018 06:01

Feb 9 (Reuters)-  
          Oncolys Biopharma Inc.  
          PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                  Year ended       Year ended       Year to       NEXT    
               Dec 31, 2017     Dec 31, 2016   Dec 31, 2018     YEAR      
                  LATEST          YEAR-AGO        COMPANY      COMPANY    
                 RESULTS          RESULTS        FORECAST    H1 FORECAST  
  Sales          229 mln          178 mln         230 mln                 
               (+28.5 pct)      (+47.0 pct)     (+0.4 pct)                
  Operating     loss 1.08       loss 861 mln     loss 1.40                
  Recurring     loss 1.09       loss 864 mln     loss 1.40                
  Net           loss 1.09       loss 931 mln     loss 1.40                
  EPS        loss 106.23 yen  loss 101.18 yen   126.29 yen                
  Ann Div          NIL              NIL             NIL                   
  -Q2 Div          NIL              NIL             NIL                   
  -Q4 Div          NIL              NIL             NIL                   
   
  NOTE - Oncolys Biopharma Inc..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T  
  ((Tokyo Headline News Desk +813 6441 1812))